Clinical Trial Update: Norursodeoxycholic Acid vs. Placebo in NASH [Phase 2]

View source ↗

Summary

Phase 2 trial update for Norursodeoxycholic Acid versus placebo in nonalcoholic steatohepatitis is in an unknown status.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Nonalcoholic Steatohepatitis

Drugs mentioned

• norUrsodeoxycholic Acid (norursodeoxycholic acid)

Snippet

Sponsor: Dr. Falk Pharma GmbH | Conditions: Nonalcoholic Steatohepatitis | Phase 2 | Status: UNKNOWN